AUA 2006 - EAU Lecture on Bladder Markers Given by Dr. Teillac
Wednesday, 24 May 2006
Dr. Pierre Teillac, Secretary General of the EAU, Paris France presented the EAU lecture at the plenary session of the AUA meeting on Tuesday, May 23 2006.
read more
|
AUA 2006 - SIU Lecture on Management of Invasive Bladder Cancer given by Dr. Ghoneim
Wednesday, 24 May 2006
Dr. Mohamed Ghoneim presented the SIU lecture at the plenary session of the AUA meeting on Wednesday, May 24 2006.
read more
|
AUA 2006 - Bladder and Urethra: Anatomy, Physiology and Pharmacology
Tuesday, 23 May 2006
This program of basic research of the bladder and urethra attests to the increasing sophistication of work in this area which may lead to greater insight of the subtle complexity of lower urinary tract function and the identification of novel therapeutic targets for disorders of these organs.
read more
|
AUA 2006 - An Update On Bladder Cancer Detection and Screening
Tuesday, 23 May 2006
This session contained several papers providing a more robust sense of the role of screening and the strengths and limitations of some of the more popular detection methods.
read more
|
AUA 2006 - An Update On Bladder Cancer Basic Research
Tuesday, 23 May 2006
The discussed poster session on bladder cancer research included presentations regarding the role of individual genes in the initiation and progression of bladder cancer, new insights regarding the mechanism of BCG function and novel preclinical studies that may later lead to therapeutic applications.
read more
|
AUA 2006 - An Update On Superficial Bladder Cancer
Tuesday, 23 May 2006
The report by Herr and Donat [ABST829] affirmed the role of repeat transurethral resection of bladder tumors in the staging of bladder lesions and the information regarding progression of lesions based on the reTUR data.
read more
|
AUA 2006 - Bladder Cancer Detecting And Screening II
Tuesday, 23 May 2006
This session discussed long term outcomes in several techniques for treatment of localized disease and intermediate outcomes in the application of newer techniques.
read more
|
AUA 2006 - Society of Urologic Oncology Meeting: Hot Topics in GU Cancer Biology And Translation; Signaling
Monday, 22 May 2006
The annual meeting of the Society of Urologic Oncology took place on Saturday, May 20, 2006 during the annual American Urological Association Meeting in Atlanta, Georgia. Dr. James Brooks, Stanford University moderated a session on "Signaling".
read more
|
AUA 2006 - High Grade T1 Bladder Cancer: Who Should Undergo Early Cystectomy?
Sunday, 21 May 2006
Dr. Seth Lerner from Baylor College of Medicine moderated a point-counterpoint session by Drs. Eila Skinner from USC and Mark Soloway from Miami.
read more
|
AUA 2006 - Novel Lung-Metastasis Suppressor Gene Discovered in Bladder Cancer
Sunday, 21 May 2006
Dr. Dan Theodorescu from the University of Virginia presented exciting data outlining the discovery of a new suppressor gene implicated in the development of bladder cancer distant metastasis.
read more
|
AUA 2006 - Society of Urologic Oncology Meeting: Cystectomy vs. BCG for T1
Saturday, 20 May 2006
The annual meeting of the Society of Urologic Oncology took place on Saturday, May 20, 2006 during the annual American Urological Association Meeting in Atlanta, Georgia. In the afternoon session, Dr. Seth Lerner, Baylor College of Medicine moderated a session titled "Cystectomy vs. BCG for T1 High Grade Bladder Cancer". In his introduction, Dr. Lerner pointed out that the presence of CIS clearly worsens the prognosis of stage T1G3 TCC.
read more
|
AUA 2006 - Matritech's NMP22® BladderChek® Test will be Featured in Presentations at the American Urological Association (AUA) Annual Meeting
Saturday, 20 May 2006
Newton, MA (May 17, 2006) - Matritech (Amex: MZT), a leading developer and marketer of protein-based diagnostic products for the early detection of cancer, announced that the NMP22® BladderChek® Test will be featured in a podium presentation and a discussed poster presentation during the May 20-25, 2006 annual meeting of the American Urological Association (AUA) in Atlanta, Georgia.
read more
|
AUA 2006 - UM UROLOGY CHAIR PRESENTS AT TOP ANNUAL UROLOGY MEETING AND IN NATIONAL MEDICAL EDUCATION COURSE ON BLADDER CANCER
Saturday, 20 May 2006
Mark S. Soloway, M.D., chairman of the Department of Urology at the University of Miami Leonard M. Miller School of Medicine, provides the introduction on a continuing medical education course on bladder cancer being distributed to urologists around the country beginning this week.
read more
|
AUA 2006 - Screening High Risk Patients For Bladder Cancer Is Cost-Effective
Saturday, 20 May 2006
Presentor: Yair Lotan, M.D., Urologist, University of Texas Southwestern Medical Center at Dallas
read more
|
BioXell Announces Phase II Results For Elocalcitol In Overactive Bladder
Friday, 12 May 2006
Milan , Italy , 11 th May, 2006 – BioXell S.p.A. today reported clear efficacy of its lead compound, Elocalcitol (previously BXL628), in a Phase II study in Overactive Bladder (OAB). In the recently concluded trial, Elocalcitol demonstrated numerical superiority on its primary endpoint and statistically significant efficacy in several clinically relevant subgroups compared to placebo. The study, a placebo-controlled, double-blind, 3-month trial involving 114 patients with OAB, also showed that Elocalcitol continues to be extremely well tolerated, with an adverse event profile comparable to placebo.
read more
|
Dietary Folate Intake May Decrease Risk Of Bladder Cancer
Tuesday, 09 May 2006
BERKELEY, CA (UroToday.com) - Genetic alterations, epigenetic events and environmental exposures all contribute to the development of bladder cancer. It is suggested that some factors, such as vitamins can decrease the risk of bladder cancer. Dr. Schabath and colleagues hypothesized that dietary folate, which is involved in DNA methylation may have a chemopreventive effect in the bladder. Their study results appeared in Nutrition and Cancer.
read more
|
Apoptosis Receptor Holds Potential As Urinary Marker For Bladder Cancer
Friday, 05 May 2006
BERKELEY, CA (UroToday.com) - Cystoscopy remains the gold standard for detection of recurrent transitional cell carcinoma (TCC) of the bladder. Cytology and other markers are used to improve sensitivity and potentially decrease the frequency of cystoscopies.
read more
|
NMP22® BladderChek® Test to be Introduced to U.S. Gynecologists at the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical Meeting
Thursday, 04 May 2006
Women Have a Disproportionately Higher Death Rate from Bladder Cancer than Men
The Company is Introducing the Only FDA Approved Point-of-care Test for Both the Detection and Monitoring of Bladder Cancer to Women’s Healthcare Specialists
Recent Clinical Data Showed the Test Detected 100% of Dangerous Tumors in Women at Risk for Bladder Cancer
read more
|
Wisconsin Urologist Reports Wisconsin Industrial Workers Might Be At Increased Risk For Bladder Cancer
Thursday, 04 May 2006
A larger percentage of women than men have life-threatening (or advanced) bladder cancer at diagnosis. The incidence rate is going down in men but up in women. Therefore, in women, symptoms of common urinary infection like urgency and blood, need to be investigated thoroughly so not to miss bladder cancer.
read more
|
European Urology - Management of BCG ?Failures?
Monday, 01 May 2006
Bacillus Calmette-Guérin (BCG) into the bladder has been demonstrated as an efficacious adjuvant treatment for superficial bladder cancer.
read more
|
Single-Dose Carboplatin Comparable To Prophylactic Radiotherapy For Stage I Seminoma: Results Of A Randomized Trial
Thursday, 13 April 2006
BERKELEY, CA (UroToday.com) - The risk of relapse for patients with stage I seminoma has traditionally ranged between 10 and 15%, depending on the local pathological characteristics of the tumor.
read more
|
Prolonged Survival Linked To Intravenous Vitamin C Seen In Three Cancer Patients
Tuesday, 11 April 2006
NEW YORK (Reuters Health) - Researchers at the National Institutes of Health and colleagues in Canada report three cases in which high-dose intravenously administered vitamin C apparently led to longer-than-expected survival in patients with advanced cancer. Two of them show long-term survival without evidence of disease.
read more
|
Initial Diagnosis Of Bladder Cancer Using A Point-Of-Care Assay
Thursday, 06 April 2006
BERKELEY, CA (UroToday.com) - EAU 2006 - XXI Annual Congress
INTRODUCTION AND OBJECTIVE: Both cystoscopy and a urine test are frequently used for the initial diagnosis of bladder cancer.
read more
|
Immediate Intravesical Mitomycin C After Bladder Tumor Resection Safe
Tuesday, 04 April 2006
NEW YORK (Reuters Health) - Intravesical instillation of mitomycin C is feasible and safe to perform in the operating room immediately after transurethral resection of superficial bladder cancers, UK-based clinicians report.
read more
|
Tissue-Engineered Bladders Successfully Used To Augment Cystoplasty
Tuesday, 04 April 2006
NEW YORK (Reuters Health) - For the first time, researchers have bioengineered a bladder using cultured autologous cells to reconstruct human bladders damaged by congenital abnormalities, investigators report in The Lancet, published online on April 4.
read more
|
Prothymosin-Alpha May Help Spot Bladder Cancer
Monday, 03 April 2006
NEW YORK (Reuters Health) - Urinary levels of nuclear protein prothymosin-alpha may be of use in finding and monitoring bladder cancer, according to Taiwanese researchers.
read more
|
Serum Tumor Markers Predict Extravesical Disease In Clinical Stage T2 Bladder Cancer
Thursday, 30 March 2006
BERKELEY, CA (UroToday.com) - Bladder cancer clinical staging is notoriously poor in patients with muscle invasive disease.
read more
|
Virtual Cystoscopy Produces Real Results
Thursday, 30 March 2006
NEW YORK (Reuters Health) - Virtual cystoscopy with CT imaging using a dilute contrast medium and computer rendering is effective in detecting certain bladder tumors, researchers report in the March issue of the Journal of Urology.
read more
|
Women Have a Disproportionately Higher Death Rate from Bladder Cancer than Men
Thursday, 23 March 2006
BERKELEY, CA (UroToday.com) - CLINICAL BRIEF: (Toronto, March 23, 2006, 6:30 PM EST) Society for Gynecologic Investigation (SGI), Scientific Poster 332, "Detection of Bladder Cancer in Women Using a Point-of-Care Assay."
read more
|
Post-Operative Instillation Of Intravesical Mitomycin C Is Safe
Friday, 10 March 2006
BERKELEY, CA (UroToday.com) - Recurrence rates following transurethral resection of bladder tumors (TURBT) are significant.
read more
|
Study Assesses NMP22 in Combination With Cystoscopy To Detect Recurrent Bladder Tumors
Friday, 17 February 2006
BERKELEY, CA (UroToday.com) - The purpose of urinary bladder markers is ideally to minimize the need for cystoscopy in the detection of bladder cancer.
read more
|
European Urology - Watchful Waiting for Low-Grade Ta Bladder Tumours: The Idea would have been Unacceptable 30 Years Ago, but Nowadays We are Highly Interested in the Results of This Study Exploring It
Friday, 17 February 2006
In the 1970s, when intravesical chemotherapy and
BCG were developed, doctors advocated more
aggressive treatment against superficial bladder
tumours.
read more
|
Improving Sexual Function In Women Undergoing Radical Cystectomy
Monday, 13 February 2006
BERKELEY, CA (UroToday.com) - Radical cystectomy (RC) in women has historically included a complete anterior exenteration to include the lateral vaginal walls and urethra.
read more
|
Sex Hormones Play A Role In Bladder Cancer In Women
Friday, 10 February 2006
NEW YORK (Reuters Health) - Menopausal status as well as age at menopause may modify the risk of women developing bladder cancer, researchers suggest in the February 1st issue of the American Journal of Epidemiology.
read more
|
A Shared Environment And Husband With Cancer Does Not Increase Risk Of Breast Cancer For The Wife
Thursday, 09 February 2006
BERKELEY, CA (UroToday.com) - Spouses share epigenetic exposures such as environment, diet, and lifestyle to include stress. As such, it is plausible that a husband with a diagnosis of cancer may correlate with an increased incidence of cancer in the wife.
read more
|
Heavy Marijuana Use Linked To Higher Risk Of Bladder Cancer
Tuesday, 07 February 2006
NEW YORK (Reuters Health) - A new study suggests marijuana smoking increases the risk of transitional cell bladder carcinoma, according to the results of a study of middle-age men who were seen at two Veterans Administration facilities.
read more
|
Lilly Initiates Clinical Trials On Second Cancer Drug Discovered In Isis Collaboration
Tuesday, 07 February 2006
CARLSBAD, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced today that Eli Lilly and Company (NYSE: LLY) has initiated clinical trials of LY2275796 in cancer patients.
read more
|
Ask The ASCO Expert Events In March On PLWC
Friday, 03 February 2006
During the month of March, the American Society of Clinical Oncology's
(ASCO) patient information website, People Living With Cancer (www.plwc.org) will host two Ask the ASCO Expert events.
read more
|
Atorvastatin Acts Against Bladder Cancer In Vitro
Wednesday, 01 February 2006
NEW YORK (Reuters Health) - Atorvastatin, the widely prescribed HMG-CoA reductase inhibitor, shows significant action against human carcinoma cells, according to researchers.
read more
|
BCG Plus Electromotive MMC May Be Superior To BCG Alone For Stage PT1 Bladder Cancer
Monday, 30 January 2006
BERKELEY, CA (UroToday.com) - Intravesicle BCG and Mitomycin C (MMC) are proven to decrease the recurrence rates of stage Ta, T1 and CIS bladder cancer.
read more
|
Risk Adapted Management of Clinical Stage I Seminoma
Tuesday, 24 January 2006
BERKELEY, CA (UroToday.com) - The standard therapy for stage I seminoma has long been radical orchiectomy followed by radiation therapy to the retroperitoneal and ipsilateral pelvic lymph nodes to a dose of 20-25 Gy, with a recurrence rate in the range of 3-5%, with virtually all recurrences occurring outside of the radiation portal.
read more
|
Role Of Voided Urine NMP22 Point-Of-Care Assay Clarified For Bladder Cancer Surveillance
Monday, 23 January 2006
BERKELEY, CA (UroToday.com) - Bladder cancer surveillance has traditionally consisted of a combination of cystoscopy, urine cytology, and upper urinary tract imaging.
read more
|
Matritech's NMP22® BladderChek® Test Detects Bladder Cancers In Symptomatic Patients Missed By Traditional Laboratory Test
Thursday, 19 January 2006
Savannah, Georgia (January 19, 2006) -Giora Katz, M.D., a urologist with the Lake City Veterans' Hospital in Lake City, Florida reported today that in a recent bladder cancer clinical trial including veterans hospitals, Matritech's NMP22 BladderChek Test detected three times more cases of bladder cancer in symptomatic patients than the traditional laboratory test, cytology.
read more
|
Study In The Journal of American Medical Association (JAMA) Reports Significant Improvement In Bladder Cancer Detection - 99% Of Malignancies Found
Wednesday, 18 January 2006
JAMA Reports that the NMP22® BladderChek® Test is Better at Detecting Bladder Malignancies than Current Technologies
read more
|
Urine Test Helps Detect Recurrent Bladder Cancer
Wednesday, 18 January 2006
NEW YORK (Reuters Health) - A point-of-care proteomic test that looks for nuclear matrix protein NMP22 in urine is a useful adjunct to cystoscopy in detecting recurrent bladder cancer, new research suggests.
read more
|
FISH Effective For Detecting And Monitoring Transitional Cell Carcinoma
Tuesday, 17 January 2006
NEW YORK (Reuters Health) - Fluorescence in situ hybridization (FISH) is highly sensitive in detecting new and recurrent transitional cell carcinoma of the bladder, according to a report in the December 2005 BJU International.
read more
|
Shorter Dwell Time Eases BCG Side Effects In Bladder Cancer
Thursday, 12 January 2006
NEW YORK (Reuters Health) - In bladder cancer patients with severe side effects from instillation treatment with bacillus Calmette-Guerin (BCG), reducing the dwell time may offer an alternative to reducing the dose, Swedish researchers report.
read more
|
Diagnostic Ultrasound Corporation, Maker Of The BladderScan®, Partners With International Volunteers In Urology To Sponsor Traveling Resident Scholars
Wednesday, 04 January 2006
Bothell, Wash., January 4, 2006 - Diagnostic Ultrasound Corporation (DU) is pleased to announce an agreement with International Volunteers in Urology (IVU) to sponsor two traveling resident scholars during the 2006-2007 scholarship year.
read more
|
High Grade Superficial Bladder Cancer: A Second TUR Improves Response To Intravesical BCG
Friday, 23 December 2005
BERKELEY, CA (UroToday.com) - The literature suggests that patients with high grade T1 bladder cancer may be upstaged 40 - 70% of the time after repeat resection, especially if detrusor was not present in the initial specimen.
read more
|
Review Examines Complications Of Transurethral Bladder Tumor Resection In A Residency Setting
Tuesday, 20 December 2005
BERKELEY, CA (UroToday.com) - The initial diagnosis of a suspected bladder tumor is confirmed by the pathological examination of tissue obtained during transurethral resection.
read more
|
Bladder Cancer 
